AECOM Analysts See 53% Upside, Yet Some Banks Cut Targets

Forward-Looking Analysis

Wall Street consensus for AECOM reflects a "Moderate Buy" rating among 13 analysts, with nine issuing buy ratings and four holding. The average twelve-month price target stands at $114.82, implying a significant 53.13% upside from the current price of $74.98. Targets range widely from a low of $90.00 to a high of $151.00. Recent analyst activity shows mixed sentiment regarding price adjustments. Citigroup reiterated a Buy rating with a 5-star score on July 23, 2026. Conversely, several firms lowered targets in mid-2026: Royal Bank of Canada cut its target to $105.00, Truist Financial lowered its to $102.00, and Barclays reduced its target to $90.00. KeyCorp and Robert W. Baird also lowered targets to $101.00 and $91.00, respectively. Weiss Ratings downgraded the stock to Hold (C-) in May. Earlier in the year, UBS boosted its target to $145.00, and Bank of America raised its to $118.00. Goldman Sachs, Argus, and National Bank Financial also adjusted targets downward from earlier highs, with National Bank initiating coverage at $151.00. Despite recent target reductions by major banks, the aggregate analyst view remains positive, significantly outperforming the "Hold" consensus average for the broader industrials sector.

AECOM reported strong results for 2026Q2, generating $3.80 billion in revenue. The company achieved a net income of $190.45 million, translating to an earnings per share (EPS) of $1.40. Gross profit for the quarter stood at $296.50 million. These figures demonstrate solid operational execution and profitability metrics heading into the third quarter, providing a baseline for comparison against upcoming fiscal performance indicators.

Additional News

No specific non-earnings news, such as M&A activity, new product launches, or CEO announcements, was provided in the source material for synthesis.

Summary & Outlook

AECOM demonstrates robust financial health, supported by strong Q2 revenue of $3.80 billion and profitable margins. The primary growth catalyst is the overwhelming analyst consensus favoring a "Moderate Buy," with a substantial 53.13% upside potential based on current valuations. While some recent target reductions suggest near-term caution among specific institutions like Barclays and RBC, the broader market remains optimistic. The divergence between the high price target of $151.00 and the current trading price indicates significant latent value. Overall, the outlook is bullish, driven by strong historical performance and positive long-term analyst sentiment, despite isolated short-term adjustments.